[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Acute Respiratory Distress Syndrome Ongoing Global Clinical Trials Analysis and Outlook

June 2018 | 208 pages | ID: A75FE930812EN
VPAResearch

US$ 630.00 US$ 700.00 -10 %
Offer valid until December 31, 2024!

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Acute Respiratory Distress Syndrome ongoing clinical trials report from VPA Research provides comprehensive analysis and trends in global Acute Respiratory Distress Syndrome disease clinical trials. The research work analyzes the ongoing Acute Respiratory Distress Syndrome clinical trial trends across countries and companies.

The report focuses on drugs and therapies being evaluated for Acute Respiratory Distress Syndrome treatment in active clinical development phases including phase 1, phase 2, phase 3 and phase 4 clinical trials. The report also provides trials information by region, key countries, enrollment, phases, trial status and sponsor types.

Our experienced database team dynamically updates the clinical trials data from several sources including Clinical trial registries, conferences, journals and company releases etc. Further, data is presented in user friendly manner to enable readers quick access to Acute Respiratory Distress Syndrome clinical trials.

Scope of the Report-
  • Ongoing Acute Respiratory Distress Syndrome clinical trials across regions
  • Trial information by Phase and Subjects recruited
  • Trial information by status, type, sponsor type
  • Drugs used for treatment of Acute Respiratory Distress Syndrome
  • Both observational and interventional trials analyzed
  • Leading companies and universities participating in Acute Respiratory Distress Syndrome clinical trials
Reasons to Buy
  • Track competition and design competitive advantages
  • Identify right partners to associate with for further research
  • Evaluate potential opportunities available in further clinical trials of the disease
  • Formulate business development strategies through success rates of clinical trials
  • Identify quick markets for recruiting subjects based on trials count by each market
1 TABLE OF CONTENTS

1.1 List of Figures
1.2 List of Tables

2 KEY FINDINGS, 2018

2.1 Snapshot
2.2 Overview of Acute Respiratory Distress Syndrome Trials

3 CLINICAL TRIALS TRENDS TO 2022

3.1 Ongoing Acute Respiratory Distress Syndrome Trials by Phase
3.2 Ongoing Acute Respiratory Distress Syndrome Trials by Type
3.3 Ongoing Acute Respiratory Distress Syndrome Trials by Recruitment Status

4 COUNTRY LEVEL ANALYSIS

4.1 Region wise Ongoing Acute Respiratory Distress Syndrome Trials
4.2 Top 10 Countries conducting Acute Respiratory Distress Syndrome Trials
4.3 Trials in Emerging and Developing Economies

5 COMPANY LEVEL ANALYSIS

5.1 Ongoing Acute Respiratory Distress Syndrome Trials by Sponsor Type
5.2 Acute Respiratory Distress Syndrome Subjects by Sponsor Type
5.3 Subjects Recruited by Leading Sponsors

6 ENROLMENT TRENDS TO 2022

6.1 Subjects Recruited for Acute Respiratory Distress Syndrome Trials by year
6.2 Subjects Recruited for Acute Respiratory Distress Syndrome Trials by Phase
6.3 Subjects Recruited for Acute Respiratory Distress Syndrome Trials by Trial Type
6.4 Subjects Recruited for Acute Respiratory Distress Syndrome Trials by Recruitment Status

7 ONGOING TRIALS- PHASE, ID, TITLE, LOCATION, TYPE, DURATION, RECRUITMENT STATUS, COMPANY DETAILS

7.1 Ongoing Acute Respiratory Distress Syndrome Trials- Phase
7.2 Ongoing Acute Respiratory Distress Syndrome Trials- Phase
7.3 Ongoing Acute Respiratory Distress Syndrome Trials- Phase
7.4 Ongoing Acute Respiratory Distress Syndrome Trials- Phase

8 APPENDIX

8.1 Abbreviations and Definitions
8.2 Sources and Research Methodology

LIST OF FIGURES

Figure 1: Acute Respiratory Distress Syndrome- Clinical Trials by Country
Figure 2: Acute Respiratory Distress Syndrome- Clinical Trials by Phase of Development, 2018
Figure 3: Acute Respiratory Distress Syndrome- Clinical Trials by Status, 2018
Figure 4: Acute Respiratory Distress Syndrome- Clinical Trials by Type, 2018
Figure 5: Acute Respiratory Distress Syndrome- Clinical Trials Split by Region, 2000-2018
Figure 6: Acute Respiratory Distress Syndrome- Clinical Trials by Type of Economy, 2018
Figure 7: Acute Respiratory Distress Syndrome- Enrolment by Phase, 2018
Figure 8: Acute Respiratory Distress Syndrome- Enrolment by Trial Type, 2018
Figure 9: Acute Respiratory Distress Syndrome- Enrolment by Recruitment Status, 2018
Figure 10: Acute Respiratory Distress Syndrome- Clinical Trials by Sponsor Type, 2018
Figure 11: Acute Respiratory Distress Syndrome- Enrolment by Type of Sponsors
Figure 12: Acute Respiratory Distress Syndrome- Enrolment by Leading Sponsors

LIST OF TABLES

Table 1: Acute Respiratory Distress Syndrome- Clinical Trials by Sponsor Type, 2018
Table 2: Acute Respiratory Distress Syndrome- Clinical Trials by Economy Type, 2018
Table 3: Acute Respiratory Distress Syndrome- Clinical Trials by Region, 2018
Table 4: Acute Respiratory Distress Syndrome- Clinical Trial Participations of Top 10 Countries, 2018
Table 5: Acute Respiratory Distress Syndrome- Clinical Trials in Emerging and Developing Economies, 2018
Table 6: Acute Respiratory Distress Syndrome- Ongoing Phase 1 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 7: Acute Respiratory Distress Syndrome- Ongoing Phase 2 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 8: Acute Respiratory Distress Syndrome- Ongoing Phase 3 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 9: Acute Respiratory Distress Syndrome- Ongoing Phase 4 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company


More Publications